Prior to the agency’s announcement via news release, the intravenous treatment had been limited to hospitalized COVID-19 patients.
Remdesivir reduced hospitalizations in COVID-19 patients at high risk for severe progression of the disease, according to data published in December in the New England Journal of Medicine.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
